Patents by Inventor Stephen M. Gunnigle

Stephen M. Gunnigle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150190504
    Abstract: The present invention relates to the use of p38 MAP kinase inhibitors and p38 MAP kinase inhibition to promote wound healing.
    Type: Application
    Filed: January 13, 2015
    Publication date: July 9, 2015
    Inventor: STEPHEN M. GUNNIGLE
  • Patent number: 8957076
    Abstract: The present invention relates to the use of p38 MAP kinase inhibitors and p38 MAP kinase inhibition to promote wound healing.
    Type: Grant
    Filed: December 21, 2009
    Date of Patent: February 17, 2015
    Assignee: Systagenix Wound Management (US), Inc.
    Inventor: Stephen M. Gunnigle
  • Patent number: 8063052
    Abstract: The present invention relates to the use of p38 MAP kinase inhibitors and p38 MAP kinase inhibition to promote wound healing.
    Type: Grant
    Filed: August 31, 2005
    Date of Patent: November 22, 2011
    Assignee: Systagenix Wound Management (US), Inc.
    Inventor: Stephen M. Gunnigle
  • Publication number: 20100099622
    Abstract: The present invention relates to the use of p38 MAP kinase inhibitors and p38 MAP kinase inhibition to promote wound healing.
    Type: Application
    Filed: December 21, 2009
    Publication date: April 22, 2010
    Applicant: SYSTAGENIX WOUND MANAGEMENT (US), INC.
    Inventor: Stephen M. Gunnigle
  • Publication number: 20090170910
    Abstract: The present invention relates to the use of p38 MAP kinase inhibitors and p38 MAP kinase inhibition to promote wound healing.
    Type: Application
    Filed: August 31, 2005
    Publication date: July 2, 2009
    Inventor: Stephen M. Gunnigle